Pharma-Bio Serv (PBSV) Operating Leases (2020 - 2024)

Pharma-Bio Serv (PBSV) has reported Operating Leases for 5 consecutive years, with $28834.0 the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Operating Leases fell 85.14% year-over-year to $28834.0; the trailing twelve-month figure through Oct 2024 stood at $28834.0 (down 85.14% YoY), and the FY2024 full-year result was $28834.0, down 85.14% from the prior year.
• Operating Leases slipped to $28834.0 in Q4 2024 per PBSV's latest filing, from $71362.0 in the prior quarter.
• Across five years, Operating Leases topped out at $729389.0 in Q1 2020 and bottomed at $28834.0 in Q4 2024.
• Historically, Operating Leases has averaged $393144.6 across 5 years, with a median of $400460.0 in 2022.
• The sharpest annual moves came in 2021 and 2024: Operating Leases dropped 18.42% in 2021, then tumbled 85.14% in 2024.
• Over 5 years, Operating Leases stood at $629979.0 in 2020, then slipped by 22.64% to $487364.0 in 2021, then declined by 28.9% to $346509.0 in 2022, then plunged by 44.0% to $194035.0 in 2023, then sank by 85.14% to $28834.0 in 2024.
• According to Business Quant data, Operating Leases over the past three periods registered $28834.0, $71362.0, and $113044.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.